Skip to main content

Emergent BioSolutions Corporate Headquarters


Corporate Headquarters : 400 Professional Drive, Suite 400, Gaithersburg, MD 20879
Tel: 240-631-3200
Fax: 240-631-3203

Corporate Affairs : The Willard, 1455 Pennsylvania Avenue, NW, Suite 1225, Washington, DC 20004
Tel: 240-631-3398
Fax: 240-631-3369

Research & Development

Gaithersburg, MD : 300 Professional Drive, Gaithersburg, MD 20879
Tel: 240-631-6300
Fax: 240-631-6455

Winnipeg, Manitoba, Canada : 155 Innovation Drive, Winnipeg, MB, CA R3T 5Y3
Tel: 204-275-4200
Fax: 204-269-7003

San Diego, CA : 3985-A Sorrento Valley Blvd, San Diego, CA 92121
Tel: 858-450-9595 ext. 405

Manufacturing Operations

Baltimore, MD : 1111 S. Paca St., Baltimore, MD 21230
Tel: 410-843-5000
Fax: 484-843-4414

Hattiesburg, MS : 46 Shelby Thames Drive, Hattiesburg, MS 39402
Tel: 517-489-5172

Sales and Marketing

Gaithersburg, MD : 400 Professional Drive, Suite 400, Gaithersburg, MD 20879
Tel: 240-631-3200

Bruchsal, Germany : Emergent Sales and Marketing Germany GmbH, Vichystraße 14, 76646 Bruchsal
Tel: 0049 7251 32197031
Fax: 0049 7251 32197010

London, UK : Emergent Countermeasures International Ltd, Parkshot House, 5 Kew Road, Richmond, Surrey TW9 2PR, United Kingdom
Tel: +44 (0) 782 558 0806
UKqueries@ebsi.com
Fax: +44 (0) 20 8334 8100

Singapore : C/O Temasek Life Sciences Laboratory Ltd, 1 Research Link #01-03, National , University Singapore, Singapore 117604
Tel: +65 6822 8007 / 006
Fax: +65 6224 3327

Redwood City, CA : 555 Twin Dolphin Drive, Suite 360, Redwood City, CA 94065
Tel: 650-897-4407

Radnor, PA : 100 Matsonford Road, Building 4, Suite 201, Radnor, PA 19087
Tel: 844-232-7811 ext. 211

Toronto, Ontario, Canada : 2233 Argentia Road, East Tower - Suite 302, Mississauga, ON, CA L5N 2X7
Tel: 416-559-9850

Dublin, Ireland : 45 Fitzwilliam Square, Dublin 2, Ireland
Tel: 353-1-6344-202

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. It develops vaccines and antibody therapeutics for infectious diseases, opioid overdoses, and provides medical devices for biodefense purposes.

Comments